Anti-IL-6

#	Item
1	CMC Biologics and RuiYi Enter into an Agreement for Development of a Novel Anti-IL-6 Monoclonal Antibody Seattle, WA USA/Copenhagen, Denmark and Shanghai, China – May 14, 2013 – CMC Biologics today announced the exec Add to Reading List Source URL: www.cmcbio.com Language: English - Date: 2014-06-06 18:31:51
2	ABLYNX INITIATES THE SECOND OF TWO PHASE IIb RA STUDIES WITH ITS ANTI-IL-6R NANOBODY, PARTNERED WITH ABBVIE Phase IIb study to evaluate ALX-0061 monotherapy in adult patients with active rheumatoid arthritis (RA) who are Add to Reading List Source URL: hugin.info Language: English - Date: 2015-04-06 12:49:59 Autoimmune diseases Immune system Ablynx Vrije Universiteit Brussel Tocilizumab Monoclonal antibodies Rheumatoid arthritis Systemic lupus erythematosus Interleukin 6 Anatomy Immunosuppressants Immunology
3	APLAR 2014, Cebu, April 3, 2014 Rheumatoid Arthritis treatment with biologics Tsutomu Takeuchi, MD.PhD. Add to Reading List Source URL: aplarcongress.org Language: English - Date: 2014-04-23 05:32:38 Monoclonal antibodies Immunology Rheumatoid arthritis Etanercept Rituximab Infliximab Belimumab Anti-IL-6 TNF inhibitor Medicine Immunosuppressants Pharmacology